lorazepam and Ataxia
lorazepam has been researched along with Ataxia in 6 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| " To assess pharmacokinetic and neurochemical aspects of tolerance, lorazepam (LRZ) was administered chronically to mice via implantable osmotic pumps and rotarod ataxia, plasma and brain LRZ concentrations, benzodiazepine receptor binding in vivo and in vitro, chloride channel binding and muscimol-stimulated chloride uptake were examined in various brain regions over a 14-day period." | 3.67 | Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function. ( Barnhill, JG; Greenblatt, DJ; Miller, LG; Shader, RI, 1988) |
| "Lorazepam was most frequently ingested (13/41 identified drugs, 32%)." | 1.30 | Pediatric benzodiazepine ingestion resulting in hospitalization. ( Wiley, CC; Wiley, JF, 1998) |
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Burns, JM | 1 |
| Marino, A | 1 |
| Manno, M | 1 |
| Rhyee, S | 1 |
| Boyer, EW | 1 |
| Marchione, P | 1 |
| Vento, C | 1 |
| Marianetti, M | 1 |
| Romeo, T | 1 |
| Amabile, GA | 1 |
| Giacomini, P | 1 |
| Kohut, SJ | 1 |
| Ator, NA | 1 |
| Wiley, CC | 1 |
| Wiley, JF | 1 |
| Miller, LG | 1 |
| Greenblatt, DJ | 1 |
| Barnhill, JG | 1 |
| Shader, RI | 1 |
| Modell, JG | 1 |
| Lenox, RH | 1 |
| Weiner, S | 1 |
Other Studies
6 other studies available for lorazepam and Ataxia
| Article | Year |
|---|---|
Status epilepticus in a child secondary to ingestion of skin-lightening cream.
Topics: Anticonvulsants; Ataxia; Eating; Emergencies; Humans; Hydroquinones; Infant; Intubation, Intratrache | 2013 |
Hemiballismus in subthalamic haemorrhage: efficacy of levetiracetam.
Topics: Aged; Anti-Dyskinesia Agents; Anticonvulsants; Antihypertensive Agents; Ataxia; Cerebellum; Dose-Res | 2009 |
Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023.
Topics: Animals; Ataxia; Conditioning, Operant; Data Interpretation, Statistical; Discrimination, Psychologi | 2008 |
Pediatric benzodiazepine ingestion resulting in hospitalization.
Topics: Anti-Anxiety Agents; Ataxia; Benzodiazepines; Central Nervous System Diseases; Child; Child, Prescho | 1998 |
Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function.
Topics: Animals; Ataxia; Drug Tolerance; Lorazepam; Male; Mice; Motor Activity; Posture; Receptors, GABA-A; | 1988 |
Inpatient clinical trial of lorazepam for the management of manic agitation.
Topics: Adult; Ataxia; Bipolar Disorder; Delirium; Female; Humans; Lorazepam; Male; Middle Aged; Mood Disord | 1985 |